VAERS reports by lot

Seqirus / CSL Flu lot 185284: VAERS reports

26 VAERS reports list lot 185284 as a Seqirus / CSL Flu vaccine, received between 2016-08-18 and 2018-01-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
27%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Musculoskeletal2123%
General / Systemic (non-local)1719%
Dermatological (non-injection-site)1618%
Neurological1516%
Injection-site / Local reaction1011%
Allergic / Anaphylactic55%
Respiratory33%
Cardiac / Cardiovascular22%
Autoimmune / Immune-mediated11%
Gastrointestinal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

South Carolina3
Texas3
New York3
California3
North Carolina2
Ohio1
Oregon1
Kentucky1
Illinois1
Minnesota1
Alabama1
Georgia1

Reports by month received

2016-082
2016-095
2016-107
2016-116
2017-012
2017-021
2017-031
2017-101
2018-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.